Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gallium Maltolate by Titan Pharmaceuticals for Glioblastoma Multiforme (GBM): Likelihood of Approval
Gallium Maltolate is under clinical development by Titan Pharmaceuticals and currently in Phase I for Glioblastoma Multiforme (GBM). According to...